Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients
- PMID: 33400380
- DOI: 10.1002/ccd.29426
Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients
Abstract
Background: There is a paucity of data regarding the outcomes of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) among solid-organ transplant recipients.
Methods: Temporal trends in hospitalizations for aortic valve replacement among solid-organ transplant recipients were determined using the National Inpatient Sample database years 2012-2017. Propensity matching was conducted to compare admissions who underwent TAVR versus SAVR. The primary outcome was in-hospital mortality.
Results: The analysis included 1,730 hospitalizations for isolated AVR; 920 (53.2%) underwent TAVR and 810 (46.7%) underwent SAVR. TAVR was increasingly utilized for solid-organ transplant recipients (Ptrend = 0.01), while there was no change in the number of SAVR procedures (Ptrend = 0.20). The predictors of undergoing TAVR for solid-organ transplant recipients included older age, diabetes, and prior coronary artery bypass surgery, while TAVR was less likely utilized in small-sized hospitals. TAVR was associated with lower in-hospital mortality after matching (0.9 vs. 4.7%, odds ratio [OR] 0.19; 95% confidence interval [CI] 0.11-0.35, p < .001) and after multivariable adjustment (OR 0.07; 95% CI 0.03-0.21, p < .001). TAVR was associated with lower rate of acute kidney injury, acute stroke, postoperative bleeding, blood transfusion, vascular complications, discharge to nursing facilities, and shorter median length of hospital stay. There was no difference between both groups in the use of mechanical circulatory support, hemodialysis, arrhythmias, or pacemaker insertion.
Conclusion: This contemporary observational nationwide analysis showed that TAVR is increasingly performed among solid-organ transplant recipients. Compared with SAVR, TAVR was associated with lower in-hospital mortality, complications, and shorter length of stay.
Keywords: aortic valve disease; percutaneous intervention; transcatheter valve implantation; transplantation.
© 2021 Wiley Periodicals LLC.
Comment in
-
The best option to treat transplant recipients with severe aortic stenosis.Catheter Cardiovasc Interv. 2021 Mar;97(4):699-700. doi: 10.1002/ccd.29567. Catheter Cardiovasc Interv. 2021. PMID: 33721412 No abstract available.
References
REFERENCES
-
- Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609-1620.
-
- Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
-
- Elgendy IY, Mahmoud AN, Gad MM, Elbadawi A, Rivero F, Alfonso F. Transcatheter or surgical aortic valve replacement for low surgical risk patients: meta-analysis of randomized trials. J Am Coll Cardiol Intv. 2019;12:1399-1401.
-
- Sharma A, Gilbertson DT, Herzog CA. Survival of kidney transplant patients in the US after cardiac valve replacement. Circulation. 2010;121:2733-2739.
-
- Shah VH, Rao MK. Changing landscape of solid organ transplantation for older adults: trends and post-transplant age-related outcomes. Curr Transplant Reports. 2020;7:38-45.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical